Episode Details
Back to Episodes
Pharmaceutical Executive Daily: Alnylam Invests $250 Million in Manufacturing Facility
Published 4 months, 2 weeks ago
Description
In today’s Pharmaceutical Executive Daily, Eli Lilly and Nimbus Therapeutics announce a major licensing deal for oral obesity treatments, Hoth Therapeutics expands its intellectual property portfolio with new provisional patents, and Alnylam commits $250 million to expand manufacturing capabilities in Massachusetts.